课题基金 / 基金详情

ENGINEERING MOTOR PROTEIN TO ENHANCE GENE DELIVERY TO THE NUCLEUS

ENGINEERING MOTOR PROTEIN TO ENHANCE GENE DELIVERY TO THE NUCLEUS
改造运动蛋白以增强基因向细胞核的输送
批准号:
7367740
负责人:
FRANCIS C. SZOKA
金额:
$0.77万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2007-06-30

项目摘要

项目成果

FRANCIS C. SZOKA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Non-viral gene delivery vectors, such as liposomes and polycationic polymers, are safer than viral vectors since they do not elicit immune response and are less likely to cause other adverse biological effects on humans. However, viral vectors are significantly more effective in transporting genetic materials into cells than non-viral gene delivery systems. By utilizing non-viral vector for targeting and delivery, and adopting crucial component from viral proteins that are involved in intracellular transport of genetic materials, we may be able to assemble a hybrid vector for gene therapy that is potentially more safe and effective. To enhance transport of genetic materials from plasma membrane to the nucleus, are utilizing a modified form of nonclaret disjuctional (Ncd), a kinesin-related microtubule motor protein that is found in Drosophila. Dr. Ron Vale provided us with the Ncd plasmid, and we modified the plasmid by adding GAL4 DNA binding domain to the plasmid to make Ncd-GAL4 fusion protein that can load plasmid DNA as a cargo. In our preliminary study using luciferase reporter plasmid, we were able to show significantly increased level of luciferase activity in the cells transfected with the fusion protein and plasmid DNA with the GAL4 binding domain over the cells transfected with fusion protein and control plasmid DNA that did not contain the GAL4 binding domain. We are attempting to improve DNA transport by further modification of the Ncd-GAL4 fusion protein without perturbing the motor activity. The second part of this project involves sequence analysis of viral proteins that are thought to be involved in hijacking motor proteins of the host cell to deliver viral contents to the nucleus. We use Chimera to visualize functional domains of Ncd, and various sequence analysis tools from the RBVI resource center. We also use the Shotgun program from Dr. Patricia Babbitt's group to find distantly related proteins that have similar functions, and identify important residues or segment(s) of viral proteins that bind to mammalian motor proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Retargeting FDA Approved Anticancer Liposomal Drugs to Cancer Stem Cells
  • 批准号:
    8833239
  • 项目类别:
  • 资助金额:
    $29.89万
  • 财政年份:
    2015
  • 负责人:
    FRANCIS C. SZOKA
  • 依托单位:
Syngeneic Macrophages for Personalized Cancer Therapy
Improving Protein Delivery and Circulation via FcRn Ligands
Improving Protein Delivery and Circulation via FcRn Ligands
国内基金
海外基金
PbIMC1g通过调控actin-myosin motor功能介导动合子滑行和侵袭的分子机制研究
  • 批准号:
    82372280
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    朱晓彤
  • 依托单位:
驱动蛋白KIF21A基因motor结构域突变影响眼球运动神经发育的分子机制研究
  • 批准号:
    82371085
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    贾红艳
  • 依托单位:
SNX6介导的囊泡运输中retromer-motor运输复合体的组装及去组装的分子机制研究